Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21B P/E - EPS this Y 27.80% Ern Qtrly Grth 529.60%
Income -2.35B Forward P/E 14.94 EPS next Y 9.10% 50D Avg Chg 2.00%
Sales 11.31B PEG 1.84 EPS past 5Y -11.04% 200D Avg Chg -12.00%
Dividend 4.00% Price/Book 1.18 EPS next 5Y 13.11% 52W High Chg -36.00%
Recommedations 2.40 Quick Ratio 0.76 Shares Outstanding 255.66M 52W Low Chg 10.00%
Insider Own 0.06% ROA 1.40% Shares Float 255.08M Beta 1.23
Inst Own 95.25% ROE -14.68% Shares Shorted/Prior 3.11M/2.87M Price 82.34
Gross Margin 34.27% Profit Margin -20.82% Avg. Volume 2,224,687 Target Price 103.61
Oper. Margin 8.69% Earnings Date Nov 4 Volume 1,170,753 Change -2.35%
About International Flavors & Fragran

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally. It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds used in savory products; beverages; sweets; and dairy products. It also provides value-added spices and seasoning ingredients; savory solutions, including spices, sauces, marinades, and mixtures; and natural antioxidants and anti-microbials. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals, natural gums, and resins; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems for cosmetic and personal care product industries. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.

International Flavors & Fragran News
12/19/24 IFF Announces Board of Directors Changes
12/12/24 A New Era of Customer-Centricity with IFF Pharma Solutions' AnswerCenter Platform
12/10/24 IFF Names Michael DeVeau Chief Financial Officer
12/05/24 International Flavors (IFF) Up 2% Since Last Earnings Report: Can It Continue?
12/04/24 Should You Think About Buying International Flavors & Fragrances Inc. (NYSE:IFF) Now?
12/02/24 Are Options Traders Betting on a Big Move in International Flavors (IFF) Stock?
11/20/24 International Flavors & Fragrances (IFF): A Top Food Stock Pick for Hedge Funds
11/14/24 IFF Launches TEXSTAR™, Pioneering Enzyme Set to Transform Fresh Fermented Food Textures
11/12/24 International Flavors & Fragrances (IFF): Balancing Stability and Growth in Diverse Markets
11/11/24 International Flavors (IFF) International Revenue Performance Explored
11/08/24 Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
11/07/24 International Flavors & Fragrances Inc (IFF) Q3 2024 Earnings Call Highlights: Strong ...
11/07/24 Down -14.15% in 4 Weeks, Here's Why International Flavors (IFF) Looks Ripe for a Turnaround
11/07/24 International Flavors & Fragrances Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
11/06/24 International Flavors Q3 Earnings Miss Estimates, Sales Rise Y/Y
11/06/24 Decoding International Flavors & Fragrances Inc (IFF): A Strategic SWOT Insight
11/05/24 International Flavors (IFF) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
11/05/24 International Flavors (IFF) Q3 Earnings Lag Estimates
11/05/24 International Flavors: Q3 Earnings Snapshot
11/05/24 IFF Reports Third Quarter 2024 Results
IFF Chatroom

User Image PenkeTrading Posted - 5 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of International Flavors & Fragrances Inc. Is that bullish or bearish? $IFF #RsiOversold #NYSE

User Image Estimize Posted - 3 weeks ago

Wall St is expecting 0.82 EPS for $IFF Q4 [Reporting 02/05 AMC] http://www.estimize.com/intro/iff?chart=historical&metric_name=eps&utm_cont

User Image RosaAtchison819 Posted - 1 month ago

$IFF While RAD Security is forging ahead, KSCP struggles to maintain any foothold in the competitive landscape.

User Image Coldoyster Posted - 1 month ago

$IFF I can’t help but wonder if this is a reaction to RFK Jr.’s pending appointment as the head of the US Department of Health and Human Services. 🤔

User Image Yothewish Posted - 1 month ago

$IFF WHY ISN‘t TEXSTAR MOVING THE STOCK..🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸🥸

User Image Jleon1793 Posted - 1 month ago

$IFF oversold on both the daily and weekly 👀

User Image GinChilla Posted - 1 month ago

$IFF Is this getting crushed because they import raw and finished product? Can't be off this much on decent earnings and upward revision

User Image texhorns925 Posted - 1 month ago

$IFF no reaction?

User Image DonCorleone77 Posted - 1 month ago

$IFF IFF raises FY24 revenue view to $11.3B-$11.4B from $11.1b-$11.3B FY24 revenue consensus $11.29B. The Company is increasing its expectations for the full year 2024. It now expects sales to be in the range of $11.3 billion to $11.4 billion versus the previously expected range of $11.1 billion to $11.3 billion, and adjusted operating EBITDA to be at the high-end of its previously communicated guidance range of $2.1 billion to $2.17 billion. The Company now expects volume to increase 5% to 6% versus the previously expected range of 3% to 5%, with improvements across the majority of the portfolio. Pricing impact is now expected to be flat versus approximately a 1% increase previously, principally driven by the impact of foreign exchange rate changes in emerging markets where the Company has index pricing to US and/or EURO exchange rates.

User Image DonCorleone77 Posted - 1 month ago

$IFF IFF reports Q3 adjusted EPS $1.04 ex-amortization, consensus $1.08 Reports Q3 revenue $2.9B, consensus $2.83B. "We are pleased to report a strong performance in the third quarter, with growth across all business segments," stated IFF CEO Erik Fyrwald. "Market recovery off prior year lows and our global team's passion to address the needs of our customers drove notable volume recovery in every division. This achievement, coupled with our focus on productivity, has resulted in significant bottom-line improvement compared to the same period last year. Taking into account our strong performance in the third quarter and our continued cautiously optimistic outlook for the fourth quarter, we are increasing our full year 2024 financial guidance. We are making solid progress but have a lot of exciting work ahead of us to unleash the full potential of IFF."

User Image Estimize Posted - 1 month ago

$IFF reports after the close, Estimize Consensus +0.05 EPS and +25.89M Revs compared to WS http://www.estimize.com/iff/fq3-2024?utm_content

User Image garygb Posted - 10/27/24

$IFF Analysts like it. Good potential. I'm in.

User Image LauriceGeel Posted - 2 months ago

$IFF powers the flavor and fragrance industry, innovating with natural and sustainable ingredients for consumer products. Powered by FAAS.

User Image swingingtech Posted - 2 months ago

$IFF https://wallstreetwaves.com/insights-and-predictions-for-international-flavors-fragrances-q3-2024-earnings-release/

User Image WeeklyTrader Posted - 2 months ago

How are you feeling about $IFF's future? RSI: 61.66% 50-day MA: $101.35 200-day MA: $91.19

User Image MoonBearTrading Posted - 2 months ago

$IFF Closed for a profit. Up $500 on it. I was late to mention it because I was on a flight, just landed, but this one was another W fellas. Follow me to get on these.

User Image Thestocktraderhubzee Posted - 2 months ago

WATCHLIST OCT 14 2024.. $TSLA Goldman Sachs Reiterates Neutral on Tesla, Maintains $230 Price Target $SRRK BMO Capital Maintains Outperform on Scholar Rock Holding, Raises Price Target to $38 $SPT Barclays Maintains Overweight on Sprout Social, Lowers Price Target to $38 $IFF Barclays Maintains Equal-Weight on Intl Flavors & Fragrances, Raises Price Target to $99 $EPC Barclays Maintains Equal-Weight on Edgewell Personal Care, Lowers Price Target to $37

User Image LeaverTrades Posted - 2 months ago

$IFF Looking like it might be ready to make a next move higher. Keep an eye on it for monday. Weekly Chart looks favourtable for further upside. Own the trade? Own the outcome. #StockMarketIdeas #stocks #stockstofocus #Trading

User Image WeeklyTrader Posted - 2 months ago

What’s your strategy for navigating $IFF’s fall? RSI: 51.37% 50-day MA: $101.17 200-day MA: $91.07

User Image MoonBearTrading Posted - 2 months ago

$IFF I lied a bit. I ended up move my stop loss to breakeven at 100.92. So I'm still in this one.

User Image IN0V8 Posted - 2 months ago

$IFF Opportunity Citigroup ups PT to $117 from $110

User Image Himel92 Posted - 2 months ago

The Last month Performance for $IFF Opening Price: $103.59 Closing Price: $102.00 Highest Price: $105.96 Lowest Price: $99.60 Percentage Change: -1.53% Data analyst: ZENA

User Image MoonBearTrading Posted - 2 months ago

$IFF Might put my stop just under the bar that formed today, rejecting at a 50% retracement from the bottom, which is a little worrying. And at the lower portion of a swing low from a couple weeks ago. So given all of this info I'm going to so we can reduce our risk, even if it does do that I'll be in profit from the trade, which is a good spot.

User Image MoonBearTrading Posted - 2 months ago

$SPY $IFF $DOC - Didn't see anything I like last night during my analysis. Closed doc last week for a small loss. Entered IFF yesterday.

User Image MoonBearTrading Posted - 2 months ago

$IFF Beautiful entry today. Closed above 1R, phenomenal.

User Image MoonBearTrading Posted - 2 months ago

$IFF Looking really good. Entry: 100.92 SL: 99.57 PT: 103.62. The only thing I don't like about this one is we've made a lower low, however, we're bouncing at a huge prior resistance zone on volume, so I like the risk to reward on this one. Especially since we're not looking to make a new high, just a small bounce back up to 103.62, prior high is at 106.

User Image Stock_Titan Posted - 3 months ago

$IFF IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024 https://www.stocktitan.net/news/IFF/iff-pharma-solutions-brings-new-innovations-and-excipient-excellence-8xj681vvaz8h.html

User Image AdamantiumBull Posted - 3 months ago

$IFF Anyone notice the massive call option position opened yesterday for Jan 2026? Over $20M spent in premiums. $110 strike. Someone MUST know something.

User Image GambitMentality Posted - 3 months ago

Midway through today, here is where the most money is flowing in the #StockMarket with #OptionsTrading. With the Top 3 spots being held by: $IFF $15.4 million on 01/16/26 $110 CALLs $IFF $15.4 million on 01/16/26 $110 CALLs $IFF $15.4 million on 01/16/26 $110 CALLs

User Image GambitMentality Posted - 3 months ago

Running a bit late on getting this out, but Midway through today, here are the most traded #Stock #Options by volume led by $TSLA $IFF and $VLY to lead the TOP 3

Analyst Ratings
Oppenheimer Outperform Sep 11, 24
JP Morgan Overweight Sep 6, 24
Mizuho Outperform Sep 3, 24
UBS Neutral Aug 15, 24
JP Morgan Overweight Aug 8, 24
Wells Fargo Overweight Aug 8, 24
UBS Neutral Aug 7, 24
Stifel Buy Jul 22, 24
Citigroup Buy Jul 12, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Fortanet Francisco EVP, Operations EVP, Operations Aug 11 Sell 125.0000 10,000 1,250,000 17,237 08/15/22
Fauchon de Villeplee Christoph... President, Scent President, Scent Jun 01 Sell 132.5900 629 83,399 8,180 06/02/22
Fauchon de Villeplee Christoph... President, Scent President, Scent May 02 Sell 121.6800 630 76,658 8,809 05/03/22
Fauchon de Villeplee Christoph... President, Scent President, Scent Apr 01 Option 59.05 2,461 145,322 9,695 04/05/22
Herriott Simon President Health & B.. President Health & Biosciences May 17 Option 115.48 1,513 174,721 2,847 05/17/21
Herriott Simon President Health & B.. President Health & Biosciences May 17 Sell 138.47 1,332 184,442 1,515 05/17/21